Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative indocyanine green fluorescence imaging for sinonasal tumor surgery
ChiCTR2500107949Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in Nasal neoplasm, sponsored by Chinese PLA General Hospital. Primary endpoint: tumor-background ratio. Started Aug 2025; status: completed.
02
Drugs
indocyanine green
03
Conditions
Nasal neoplasm
Beyond the preview
Go deeper on ChiCTR2500107949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107949.